SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

ILCS 2026 · Our Partners

Sponsors

The companies whose support makes the International Lung Cancer Summit possible.

13 Partners · ILCS 2026

Platinum

AstraZenecaPharmaMarAmgen

Gold

MSD

Silver

Bronze

ILCS 2026 is made possible through the generous support of the sponsors shown above. Financial support does not constitute or imply endorsement by ILCS of any company, product, or service. Sponsors have no control over, or input into, the independent scientific programme and accredited educational content.Placeholder disclosure wording — confirm with legal before launch.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates